Trial intelligence / Profile preview

Memantine for Cocaine Dependence

NCT00134901Phase 2Completed

Sponsor
New York State Psychiatric Institute
Start
Mar 2003
Primary completion
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of memantine in cocaine dependence, sponsored by New York State Psychiatric Institute. Started Mar 2003; status: completed.

02

Drugs

memantine
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00134901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00134901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call